224 related articles for article (PubMed ID: 32638579)
1. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
Maria AG; Tatsi C; Berthon A; Drougat L; Settas N; Hannah-Shmouni F; Bertherat J; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Sep; 27(9):509-517. PubMed ID: 32638579
[TBL] [Abstract][Full Text] [Related]
2. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
3. Use of 3-Dimensional Volumetric Modeling of Adrenal Gland Size in Patients with Primary Pigmented Nodular Adrenocortical Disease.
Chrysostomou PP; Lodish MB; Turkbey EB; Papadakis GZ; Stratakis CA
Horm Metab Res; 2016 Apr; 48(4):242-6. PubMed ID: 27065461
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
5. A novel pathogenic variant of ARMC5 in a patient with primary bilateral macronodular adrenal hyperplasia: a case report.
Wang W; Wei F
BMC Endocr Disord; 2022 Aug; 22(1):211. PubMed ID: 35996143
[TBL] [Abstract][Full Text] [Related]
6. Allelic Variants of
Mariani BMP; Nishi MY; Wanichi IQ; Brondani VB; Lacombe AMF; Charchar H; Pereira MAA; Srougi V; Tanno FY; Ceccato F; Regazzo D; Barbot M; Occhi G; Albiger NME; Vieira-Corrêa M; Kater CE; Scaroni C; Chambô JL; Zerbini MCN; Mendonca BB; Almeida MQ; Fragoso MCBV
Front Endocrinol (Lausanne); 2020; 11():36. PubMed ID: 32117062
[No Abstract] [Full Text] [Related]
7. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
Tang P; Zhang J; Peng S; Yan X; Wang Y; Wang S; Zhang Y; Liu G; Xu J; Huang Y; Zhang D; Liu Q; Jiang J; Lan W
BMC Endocr Disord; 2023 Apr; 23(1):77. PubMed ID: 37029354
[TBL] [Abstract][Full Text] [Related]
8. Update of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome.
Berthon A; Bertherat J
Horm Metab Res; 2020 Aug; 52(8):598-606. PubMed ID: 32097969
[TBL] [Abstract][Full Text] [Related]
9. Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) - case reports with literature review.
Pasternak-Pietrzak K; Stratakis CA; Moszczyńska E; Lecka-Ambroziak A; Staniszewski M; Wątrobińska U; Lyssikatos C; Prokop-Piotrkowska M; Grajkowska W; Pronicki M; Szalecki M
Endokrynol Pol; 2018; 69(6):675-681. PubMed ID: 30259502
[TBL] [Abstract][Full Text] [Related]
10. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
London E; Rothenbuhler A; Lodish M; Gourgari E; Keil M; Lyssikatos C; de la Luz Sierra M; Patronas N; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2014 Feb; 99(2):E303-10. PubMed ID: 24248186
[TBL] [Abstract][Full Text] [Related]
11. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.
Sahut-Barnola I; de Joussineau C; Val P; Lambert-Langlais S; Damon C; Lefrançois-Martinez AM; Pointud JC; Marceau G; Sapin V; Tissier F; Ragazzon B; Bertherat J; Kirschner LS; Stratakis CA; Martinez A
PLoS Genet; 2010 Jun; 6(6):e1000980. PubMed ID: 20548949
[TBL] [Abstract][Full Text] [Related]
12. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
13. ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
Espiard S; Drougat L; Libé R; Assié G; Perlemoine K; Guignat L; Barrande G; Brucker-Davis F; Doullay F; Lopez S; Sonnet E; Torremocha F; Pinsard D; Chabbert-Buffet N; Raffin-Sanson ML; Groussin L; Borson-Chazot F; Coste J; Bertagna X; Stratakis CA; Beuschlein F; Ragazzon B; Bertherat J
J Clin Endocrinol Metab; 2015 Jun; 100(6):E926-35. PubMed ID: 25853793
[TBL] [Abstract][Full Text] [Related]
14. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH).
Giacché M; Panarotto A; Mori L; Poliani PL; Lanzi R; Lena MS; Castellano M
Mol Genet Genomic Med; 2023 Apr; 11(4):e2126. PubMed ID: 36727580
[TBL] [Abstract][Full Text] [Related]
15. Children with Cushing's syndrome: Primary Pigmented Nodular Adrenocortical Disease should always be suspected.
da Silva RM; Pinto E; Goldman SM; Andreoni C; Vieira TC; Abucham J
Pituitary; 2011 Mar; 14(1):61-7. PubMed ID: 20924687
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia.
Vassiliadi DA; Tsagarakis S
Endocr Relat Cancer; 2019 Oct; 26(10):R567-R581. PubMed ID: 32053747
[TBL] [Abstract][Full Text] [Related]
18. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.
Berthon A; Hannah-Shmouni F; Maria AG; Faucz FR; Stratakis CA
J Steroid Biochem Mol Biol; 2019 Jul; 191():105316. PubMed ID: 31014964
[TBL] [Abstract][Full Text] [Related]
19. c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.
Nadella K; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Oct; 27(10):591-599. PubMed ID: 32738126
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary Cushing's syndrome caused by primary bilateral macronodular adrenal hyperplasia due to ARMC5 mutation with concomitant primary hyperparathyroidism: the first known case in Russia].
Mamedova EO; Vasilyev EV; Petrov VM; Izmailova NS; Buryakina SA; Rozhinskaya LY; Tiulpakov AN; Belaya ZE
Probl Endokrinol (Mosk); 2019 Jun; 65(2):89-94. PubMed ID: 31271710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
